Nangino Glaucio de Oliveira, Oliveira Cláudio Dornas de, Correia Paulo César, Machado Noelle de Melo, Dias Ana Thereza Barbosa
Santa Casa de Belo Horizonte - Belo Horizonte (MG), Brazil.
Rev Bras Ter Intensiva. 2012 Dec;24(4):357-61. doi: 10.1590/s0103-507x2012000400011.
Infections in intensive care units are often associated with a high morbidity and mortality in addition to high costs. An analysis of these aspects can assist in optimizing the allocation of relevant financial resources.
This retrospective study analyzed the hospital administration and quality in intensive care medical databases [Sistema de Gestão Hospitalar (SGH)] and RM Janus®. A cost analysis was performed by evaluating the medical products and materials used in direct medical care. The costs are reported in the Brazilian national currency (Real). The cost and length of stay analyses were performed for all the costs studied. The median was used to determine the costs involved. Costs were also adjusted by the patients' length of stay in the intensive care unit.
In total, 974 individuals were analyzed, of which 51% were male, and the mean age was 57±18.24 years. There were 87 patients (8.9%) identified who had nosocomial infections associated with the intensive care unit. The median cost per admission and the length of stay for all the patients sampled were R$1.257,53 and 3 days, respectively. Compared to the patients without an infection, the patients with an infection had longer hospital stays (15 [11-25] versus 3 [2-6] days, p<0.01), increased costs per patient in the intensive care unit (median R$9.763,78 [5445.64 - 18,007.90] versus R$1.093,94 [416.14 - 2755.90], p<0.01) and increased costs per day of hospitalization in the intensive care unit (R$618,00 [407.81 - 838.69] versus R$359,00 [174.59 - 719.12], p<0.01).
Nosocomial infections associated with the intensive care unit were determinants of increased costs and longer hospital stays. However, the study design did not allow us to evaluate specific aspects of cause and effect.
重症监护病房的感染除了成本高昂外,还常常与高发病率和高死亡率相关。对这些方面进行分析有助于优化相关财政资源的分配。
这项回顾性研究分析了重症监护医学数据库[Sistema de Gestão Hospitalar (SGH)]和RM Janus®中的医院管理和质量情况。通过评估直接医疗护理中使用的医疗产品和材料进行成本分析。成本以巴西本国货币(雷亚尔)报告。对所有研究成本进行了成本和住院时间分析。使用中位数来确定所涉及的成本。成本也根据患者在重症监护病房的住院时间进行了调整。
总共分析了974人,其中51%为男性,平均年龄为57±18.24岁。有87名患者(8.9%)被确定患有与重症监护病房相关的医院感染。所有抽样患者每次入院的中位数成本和住院时间分别为1257.53雷亚尔和3天。与未感染的患者相比,感染患者的住院时间更长(15[11 - 25]天对3[2 - 6]天,p<0.01),重症监护病房每位患者的成本增加(中位数9763.78雷亚尔[5445.64 - 18007.90]对1093.94雷亚尔[416.14 - 2755.90],p<0.01),且重症监护病房每天的住院成本增加(618.00雷亚尔[407.81 - 838.69]对359.00雷亚尔[174.59 - 719.12],p<0.01)。
与重症监护病房相关的医院感染是成本增加和住院时间延长的决定因素。然而,研究设计不允许我们评估因果关系的具体方面。